Dani Bach
Angel Investor @ +ND Capital
Zürich, Switzerland
Dani Bach is an Associate in the life sciences team, having joined the firm in 2007.Dani's areas of interest range from metabolic diseases to virology and prior to joining Index, Dani was conducting research at the Ecole Polytechnique Federal de Lausanne (EPFL), where he worked on the complex interactions between human immunodeficiency virus(HIV) and the human immune system.Dani holds a Master in Start-up Business Administration and a PhD in Molecular Biology from the Universitat de Barcelona.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Dani Bach invests in
Stages Dani Bach invests in
Countries Dani Bach invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
- Pharmaceutical 1 (33%)
Country
- Denmark 1 (33%)
- Switzerland 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vandria creates mitophagy inducers that renew cells in order to address aging and chronic disorders. | $10.1M / Series A / Aug 21, 2024 | ||
| Vandria creates mitophagy inducers that renew cells in order to address aging and chronic disorders. | $20.6M / Series A / Dec 14, 2023 | ||
| Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on serious diseases caused by epithelial injury. | $45M / Series A / May 04, 2021 |
Co-Investors
About +ND Capital
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.
+ND Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Eric Moessinger
Partner
|
|||
Jonathan Nicholson
Director
|
|||
Kirill Kuzmichev
Principal
|
|||
Louis-Philippe Lalonde
Entrepreneur-In-Residence
|
|||
Richard Coles
Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dani Bach invest in?
Dani Bach invests primarily in Life Science, Biotechnology and Manufacturing startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dani Bach?
Public channels for Dani Bach include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dani Bach last invest?
The most recent investment recorded for Dani Bach closed in Aug 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
